Group items tagged

Type 2 Diabetes Therapeutics Market to 2019 - A Shifting Treatment Algorithm and Intensified Competition Expected to Drive Growth by 2019 Summary GBI Research has released its latest report for the pharmaceuticals industry, Type 2 Diabetes Therapeutics Market to 2019 - A Shifting Treatment Algorithm and Intensified Competition Expected to Drive Growth by 2019.

The report provides insights into two therapeutic indications in ophthalmology in top eight markets of the US, the UK, France, Germany, Italy, Spain, Japan and Canada.

"Analytical Tool - Cancer Therapeutic Antibodies" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in antibody drug development for the treatment of cancer.

In this report, we have analyzed the market opportunity of Rituximab Biosimilar and its competitive landscape. We believe that despite several clinical setbacks in the Rituxan biosimilars pipeline, they could pose a challenge to Rituximab by 2018.

The report provides an overview of the approved therapies for rrmm, ndmm, aml, mds, unmet need and limitations of the current soc for relapsed and refractory pts.

This report vitiligo - pipeline review, h2 2013, provides information on the therapeutic development for vitiligo, complete with latest updates, and special features on late-stage and discontinued projects.

This report provides comprehensive information on the therapeutic development for male infertility, complete with comparative analysis at various stages, therapeutics assessment by drug target.

This report waldenstrom macroglobulinemia pipeline review 2013 provides information on the therapeutic development for waldenstrom macroglobulinemia, complete with latest updates, and special features on late-stage and discontinued projects.

This report provides information on the therapeutic development for Systemic Sclerosis (Scleroderma), complete with latest updates, and special features on late-stage and discontinued projects.

This report provides comprehensive information on the therapeutic development for Brain Cancer, complete with comparative analysis at various stages.

This report provides comprehensive information on the therapeutic development for Arthritis, complete with comparative analysis at various stages.

This report provides comprehensive information on the therapeutic development for Type 2 Diabetes, complete with comparative analysis at various stages.